Connor, Clark & Lunn Investment Management (CC&L)
VYGR icon

Connor, Clark & Lunn Investment Management (CC&L)’s Voyager Therapeutics VYGR Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,673
Closed -$230K – 1719
2024
Q1 		$230K Buy
+24,673
New +$208K ﹤0.01% 1360
2023
Q4 		– Sell
-36,425
Closed -$282K – 1579
2023
Q3 		$282K Sell
36,425
-74,584
-67% -$681K ﹤0.01% 1158
2023
Q2 		$1.27M Buy
111,009
+191
+0.2% +$1.98K 0.01% 725
2023
Q1 		$854K Sell
110,818
-5,587
-5% -$44.4K ﹤0.01% 755
2022
Q4 		$710K Buy
116,405
+4,250
+4% +$24.1K ﹤0.01% 789
2022
Q3 		$664K Sell
112,155
-8,076
-7% -$51.7K ﹤0.01% 752
2022
Q2 		$711K Sell
120,231
-13,341
-10% -$90.1K ﹤0.01% 696
2022
Q1 		$1.02M Sell
133,572
-13,962
-9% -$62.3K 0.01% 658
2021
Q4 		$400K Buy
147,534
+115,404
+359% +$394K ﹤0.01% 841
2021
Q3 		$85K Buy
+32,130
New +$104K ﹤0.01% 991
2020
Q2 		– Sell
-26,400
Closed -$242K – 1186
2020
Q1 		$242K Buy
26,400
+2,637
+11% +$30.3K ﹤0.01% 837
2019
Q4 		$331K Buy
+23,763
New +$345K ﹤0.01% 743

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s VYGR Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Voyager Therapeutics (VYGR) in Q2 2024, closing a stake of 24,673 shares — an estimated $230K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in VYGR in Q4 2019 and held it in 12 quarters. The position peaked at $1.27M in Q2 2023. 127 funds tracked by Wall St. Rank hold VYGR as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Voyager Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 24,673 Voyager Therapeutics shares in Q2 2024, an estimated $230K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Voyager Therapeutics in Q4 2019 and held it in 12 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Voyager Therapeutics position peaked at $1.27M in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.